Yoshiyama Annie
SEC insider (Form 3/4/5 filer). CIK 0001835208. SVP, Finance at Allogene Therapeutics, Inc. (ALLO). 6 reported Form 4/5 transactions since Sep 2024; latest on Apr 21, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Yoshiyama Annie has filed insider reports for
- Allogene Therapeutics, Inc. (ALLO): Officer, SVP, Finance
Yoshiyama Annie
CIK: 0001835208
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Allogene Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Apr 21, 2026ALLO
Allogene Therapeutics, Inc.
SaleDirect9.6K shares at avg. $2.31$22K - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
SaleDirect4.2K shares at avg. $1.72$7K - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectStock Option (Right to buy)
179.7K shares- - Feb 2, 2026ALLO
Allogene Therapeutics, Inc.
AwardDirectRestricted Stock Unit
50.8K shares- - Apr 21, 2025ALLO
Allogene Therapeutics, Inc.
SaleDirect9.6K shares at avg. $1.41$14K - Jan 24, 2025ALLO
Allogene Therapeutics, Inc.
AwardDirect36.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 21, 2026 | ALLO Allogene Therapeutics, Inc. | Sale | 9,586 | $2.31 | $22,144 | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Sale | 4,167 | $1.72 | $7,167 | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Award Stock Option (Right to buy) | 179,691 | - | - | Direct |
| Feb 2, 2026 | ALLO Allogene Therapeutics, Inc. | Award Restricted Stock Unit | 50,827 | - | - | Direct |
| Apr 21, 2025 | ALLO Allogene Therapeutics, Inc. | Sale | 9,601 | $1.41 | $13,537 | Direct |
| Jan 24, 2025 | ALLO Allogene Therapeutics, Inc. | Award | 36,232 | - | $0 | Direct |
1-6 of 6 transactions